New! Live After Chats

During the month of July, ASM CVS will present 2 live after chats featuring Elitza S. Theel, Ph.D.,  and Stephen J. Thomas, M.D., as they discuss the hottest topics in SARS-CoV-2 and dengue virus vaccine development.

Serologic Testing for SARS-CoV-2

Wednesday, July 21, 1 p.m. EDT

  • Elitza S. Theel, Ph.D., explores where we currently are with serologic testing for SARS-CoV-2 and its clinical utility. Watch the video to participate in the live after chat.

Dengue and Dengue Vaccines

Thursday, July 29, 2 p.m. EDT

  • Stephen J. Thomas, M.D., examines the latest research on dengue and dengue vaccine development. Watch the video to participate in the live after chat.

Schedule at a Glance

Take a look at what's in store for you at 2021 ASM CVS.

Monday, Sept. 27

8 - 8:30 a.m. | Continental Breakfast

8:30 a.m. - 3 p.m. | Edith Hsiung Practical Issues in Diagnostic Virology 

Conveners:
Jeanne Jordan, Ph.D., George Washington University, Washington, D.C.
Matthew Binnicker, Ph.D., Mayo CLinic, Rochester, Minn.

  • 8:30-9 a.m.:  Point-of-Care Molecular Assays Should Supplant CentralizedLab Testing for Diagnosis of Respiratory Viruses (Tristan W. Clark, M.D., University of Southampton, Southampton, U.K.)
  • 9-9:15 a.m.: Discussion
  • 9:15-9:45 a.m.: Demonstrating the Clinical Utility of Advanced Microbiology Tools (Charles Matthews, Principal, ClearView Healthcare Partners, Newton, Mass.)
  • 9:45-10 a.m.: Discussion

10 - 11 a.m.* | Break in Exhibit and Poster Hall

10 a.m. - 2 p.m.* | Exhibit and Poster Hall Hours

11 - 11:15 a.m. | ASM Update

Stefano Bertuzzi, Ph.D., MPH, Chief Executive Officer, ASM, Washington, D.C.

11:15 a.m. - 12:45 p.m. | Panel Discussion - Challenges/Opportunites in Clinical Virology: Will Next Generation Sequencing (NGS) Make Viral Diagnosis Better?

Moderator: 
Richard L. Hodinka, Ph.D., Perelman School of Medicine at the University of Pennsyvania, Philadelphia, Pa.
  • 11:15-11:30 a.m.: A Basic Primer on Next Generation Sequencing (Samia Naccache, Ph.D., LabCorp Diagnostic Laboratories, Seattle, Wash.)
  • 11:30-11:45 a.m.: A Physician's Perspective on the Clinical Utility of Next Generation Sequencing (Lauge Farnaes, M.D., Ph.D., University of California San Diego School of Medicine, San Diego, Calif.) 
  • 11:45 a.m.-Noon: Next Generation Sequencing from a Laboratorian's Point of View (Robin Patel, M.D., Mayo Clinic, Rochester, Minn.)
  • Noon-12:15 p.m.: Opportunities and Challenges for Next Generation Sequencing of SARS-CoV-2 (Alexander L. Greninger, M.D., Ph.D., University of Washington School of Medicine, Seattle, Wash.)
  • 12:15-12:45 p.m.: Discussion 

12:45 - 2 p.m. | Lunch in Exhibit and Poster Hall

2:15 - 3:15 p.m. | Interactive Session: Virology Jeopardy

Benjamin Pinsky, M.D., Ph.D., Stanford University School of Medicine, Palo Alto, Calif.
Ryan F. Relich, Ph.D., D(ABMM), MLS(ASCP)CMSMCM, Indiana University School of Medicine, Indianapolis, Ind.  

2:15 - 3:45 p.m. | Exhibit and Poster Hall Demo Hours

2:15 - 4:45 p.m.* | Exhibit and Poster Hall Hours

3:15 - 3:30 p.m. | Travel Awards Presentations

3:45 - 5:15 p.m.* | Poster Presentations & Reception in Exhibit Hall

*Official Exhibit Hours


Tuesday, Sept. 28

8 - 8:30 a.m. | Continental Breakfast 

8 - 10 a.m. | Exhibit and Poster Hall Demo Hours

8:30 a.m. - 12:45 p.m. | Session I: Clinical Aspects of Viral Diseases

Conveners: 
John Sever, M.D., Ph.D., Children's National Medical Center, George Washington University Medical Center, Rockville, Md. 
Kirsten St. George, Ph.D., NYSDOH Wadsworth Center, Albany, N.Y. 
  • 8:30-9 a.m.: Association Between Enteroviruses and Acute Flaccid Myelitis (Janell Routh, M.D., MHS, Centers for Disease Control and Prevention, Atlanta, Ga.)
  • 9-9:15 a.m.: Discussion
  • 9:15-9:45 a.m.: DENV-4 in AsunciĆ³n: Clinical and Laboratory Findings from the Largest Dengue Outbreak on Record  (Jesse J. Waggoner, M.D., Emory University School of Medicine, Atlanta, Ga.)

10 - 11 a.m.* | Break in Exhibit and Poster Hall

10 a.m. - 12:45 p.m.* | Exhibit and Poster Hall Hours

  • 11:15-11:45 a.m.: Measles Resurgence in the U.S. and Beyond (Kristen A. Feemster, M.D., MPH, M.S.H.P., Perelman School of Medicine at the University of Pennsylvania & Children's Hospital of Philadelphia, Philadelphia, Pa.)
  • 11:45 am.-Noon: Discussion 
  • Noon-12:30 p.m.: Complications of COVID-19 (Colleen Kraft, M.D., Emory University School of Medicine, Atlanta, Ga.)
  • 12:30-12:45 p.m.: Discussion 

1 - 2:30 p.m. | Industry & Science Workshops

3 - 4:30 p.m. | Industry & Science Workshops

4:30 - 6 p.m.* | Exhibit and Poster Hall Hours and Poster Presentations & Reception in Exhibit Hall


*Official Exhibit Hours


Wednesday, Sept. 29

8 - 8:30 a.m. | Continental Breakfast 

8 - 10 a.m. | Exhibit and Poster Hall Demo Hours

8:30 a.m. - 12:45 p.m. | Session II: Laboratory Diagnosis of Viral Diseases

Conveners: 
Melissa B. Miller, Ph.D., University of North Carolina Health,Chapel Hill, N.C.
Frederick Nolte, Ph.D., Medical University of South Carolina, Charleston, S.C. 
  • 8:30-9 a.m.: Laboratory Stewardship of Diagnostic Tests within the Clinical Virology Laboratory (Gregory A. Storch, M.D., Washington University School of Medicine, St. Louis, Mo.) 
  • 9-9:15 a.m.: Discussion 
  • 9:15-9:45 a.m.: An Update on Standardization and Harmonization of Molecular Diagnostics (Paul S. Wallace, Ph.D., Quality Control for Molecular Diagnostics (QCMD), Scotland, UK)
  • 9:45-10 a.m.: Discussion 

10 - 11 a.m.* | Break in Exhibit and Poster Hall

10 a.m. - 2:45 p.m.* | Exhibit and Poster Hall Hours

  • 11:15 a.m.-11:45 a.m.: Testing Trends and Guidelines for Screening and Monitoring of HIV Infections (Neil W. Anderson, M.D., Barnes Jewish Hospital & Washington University School of Medicine, St. Louis, Mo.)
  • 11:45-Noon: Discussion 
  • Noon-12:30 p.m.: Interdependence of Diagnostics and Epidemiology (Hubert G. Niesters, Ph.D., University of Groningen, University Medical Center, Groningen, The Netherlands)
  • 12:30-12:45 p.m.: Discussion 

12:45 - 1:45 p.m. | Lunch in Exhibit Hall

1:15 - 2:45 p.m.* | Poster Presentations

3 - 3:15 p.m. | Marilyn A. Menegus Award Presentation

3:15 - 3:45 p.m. | Late Breaker

3:45 - 4 p.m. | Break 

4 - 6 p.m. | Philip Hanff Memorial Clinical Case Presentations and Discussion 

Convener:
Richard L. Hodinka, Ph.D., Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
 
Esther Babady, Ph.D., Memorial Sloan Kettering Cancer Center, New York, N.Y.
Ana Maria Cardenas, Ph.D., BD Life Sciences, Sparks, Md. 
Marie L. Landry, M.D., Yale University School of Medicine, New Haven, Conn. 

9 - 10:30 p.m. | Evening Networking Event 


*Official Exhibit Hours

Thursday, Sept. 30

8 - 8:30 a.m. | Continental Breakfast 

8:30 - 11:45 a.m. | Session III: Prevention of and Therapy for Viral Infections 

Conveners: 
Esther Babady, Ph.D., Memorial Sloan Kettering Cancer Center, New York, N.Y.
Rangaraj Selvaragan, Ph.D., Children's Mercy Hospital and Clinics and University of Missouri Kansas City School of Medicine, Kansas City, Mo.
  • 8:30-9 a.m.: Vaccine Hesitancy and the Anti-Vaxxer Movement (Peter  J. Hotez, M.D., Ph.D., Baylor College of Medicine and Texas Children's Hospital, Houston, Texas)
  • 9-9:15 a.m.: Discussion
  • 9:15-9:45 a.m.: Targeted Inactivation of HIV-1 Proviral DNA using CRISPR/Cas (Bryan A. Cullen, Ph.D. , DSc., Duke University Medical Center, Durham, N.C.) 
  • 9:45-10 a.m.: Discussion

10 - 10:15 a.m. | Break 

  • 10:15-10:45 a.m.: Capacity Building Strategies in Dealing with a Global Outbreak of Viral Disease (William A. Fischer II, M.D., University of North Carolina School of Medicine, Chapel Hill, N.C.)
  • 10:45-11 a.m.: Discussion 
  • 11-11:30 a.m.: General Overview of Approaches to Treatment and Prevention of SARS-CoV-2/COVID-19 (Cheston B. Cunha, M.D., Brown University Alpert School of Medicine, Providence, R.I.)
  • 11:30-11:45 a.m.: Discussion 

11:45 a.m. | Closing Remarks

Program Committee

Richard Hodinka, Ph.D. | Co-chair               
University of South Carolina School of Medicine Greenville         
Greenville, S.C.

Steven Specter, Ph.D. | Co-Chair
University of South Florida
Morsani College of Medicine     
Tampa, Fla.

Benjamin Pinsky, M.D.    
Stanford University School of Medicine
Palo Alto, Calif.

Esther Babady, Ph.D., D(ABMM)    
Memorial Sloan Kettering Cancer Center
New York, N.Y.

Matthew Binnicker Ph.D.               
Mayo Clinic        
Rochester, Minn.

Ana Maria Cardenas, Ph.D., D(ABMM)
Children's Hospital of Philadelphia
New Haven, Conn.

Jeanne Jordan, Ph.D.    
George Washington University
Washington, D.C.

Kirsten St. George, Ph.D.    
NYSDOH Wadsworth Center
Albany, N.Y.
 
Melissa Miller, Ph.D., D(ABMM), F(AAM)               
University of North Carolina School of Medicine   
Chapel Hill, N.C.

Rangaraj Selvarangan, BVSc, Ph.D., D(ABMM), FIDSA       
Children's Mercy Hospitals and Clinics    
Providence, R.I.

Frederick Nolte, Ph.D., D(ABMM), F(AAM)    
Medical University of South Carolina
Charleston, S.C.